Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cardiovascular
Neuroprotection
Drug Discovery
Inflammation/Pain
Autoimmune
Technical Glossary
Publications
Investors
Investor Welcome
ASX Announcements
Share Price Information
Shareholder Meetings
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
News & Insights
Presentations & Interviews
Media
Newsletters
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Share Price Information
Shareholder Meetings
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
ASX Announcements
Filter by Year:
2022
2021
2020
21-Jan-2022
Nyrada Quarterly Activities Report & Appendix 4C
17-Jan-2022
Application for quotation of securities - NYR
17-Jan-2022
Change of Director's Interest Notice - ID
17-Jan-2022
Change of Director's Interest Notice - MF
17-Jan-2022
Change of Director's Interest Notice - RW
17-Jan-2022
Change of Director's Interest Notice - JM
17-Jan-2022
Change of Director's Interest Notice - CC
17-Jan-2022
Change of Director's Interest Notice - PM
12-Jan-2022
Nyrada Receives A$1.3M R&D Tax Incentive Rebate
4-Jan-2022
Brain Injury Program Update and Pathway to Phase I
Previous
1
2
